Ceftazidime-Avibactam To Treat Life-Threatening Infections by Carbapenem-Resistant Pathogens in Critically Ill Mechanically Ventilated Patients

Data on the effectiveness of ceftazidime-avibactam (CAZ-AVI) in critically ill, mechanically ventilated patients are limited. The present retrospective observational cohort study, which was conducted in two general intensive care units (ICUs) in central Greece, compared critically ill, mechanically...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Tsolaki, Vasiliki, Mantzarlis, Konstantinos, Mpakalis, Athanasios, Malli, Ergina, Tsimpoukas, Fotios, Tsirogianni, Athanasia, Papagiannitsis, Constantinos, Zygoulis, Paris, Papadonta, Maria-Eirini, Petinaki, Efthimia, Makris, Demosthenes, Zakynthinos, Epaminondas
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2020
Assuntos:
Clinical Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7038311/
https://ncbi.nlm.nih.gov/pubmed/31818820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02320-19
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares